BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lab901 Delivers First Next-Generation RNA QC Screentape(R) System To Oxford Gene Technology Ltd.


1/8/2010 1:58:32 PM

Edinburgh – 10 January 2010 – Lab901 today announced that it has shipped the first of its next-generation ScreenTape® systems for automated RNA QC to Oxford Gene Technology (OGT) in Oxford, UK. ScreenTape R6K is a next-generation platform for RNA QC that automatically delivers the ScreenTape Degradation Value (SDV), an objective quality metric for total RNA samples. Lab901’s ScreenTape platform eliminates steps such as gel reagent preparation, chip priming and chip-vortexing, and avoids all problems associated with cross priming and sample carry-over since individual micro-gels are used for each sample analysis.

“As OGT’s microarray R&D and service business grows, we are continually seeking opportunities to increase throughput whilst maintaining the highest standards of data quality” commented John Anson, R&D Director at OGT. “Having evaluated Lab901’s ScreenTape platform, we are keen to integrate it into our high throughput microarray facility.” Commenting on the placement, Richard Rowling, Lab901’s Sales and Marketing Director said: “Being the pioneer of microarray-based technologies, we are particularly delighted that OGT has decided to add ScreenTape R6K to their RNA QC workflow.”

Unlike the leading chip-based systems, Lab901’s ScreenTape device can be used more than once. A single sample can be run cost-effectively each time, reserving the rest of the available channels for future experiments. There is no longer any need to batch samples together or throw away unused portions of the consumable, which improves the RNA QC workflow and saves money.

For more information on Lab901’s range of ScreenTape products for automated RNA QC, SDS-PAGE and multiplex PCR diagnostics please visit www.lab901.com or call Lab901 on +44 131 448 2904

About Lab901:

Lab901 is a leading laboratory automation company. Lab901 has been selling its D800 and DS12 DNA ScreenTape products into the PCR diagnostics market for the last 18 months and to date has shipped over 70 systems globally. ScreenTape R6K for RNA QC is the latest product to be developed and manufactured at Lab901’s production facility in Loanhead, Edinburgh.

About the ScreenTape® System:

The ScreenTape system is the first fully automated, walk-away solution for gel electrophoresis. Customers simply load their samples and the ScreenTape consumable into the compact TapeStation instrument and, within 1 minute per sample, fully analysed results for protein, RNA and DNA samples are displayed.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES